Ullah Raheem, Shah Majid Ali, Tufail Soban, Ismat Fouzia, Imran Muhammad, Iqbal Mazhar, Mirza Osman, Rhaman Moazur
Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
Pakistan Institute of Engineering and Applied Sciences, P.O. Nilore, Islamabad, Pakistan.
PLoS One. 2016 Apr 19;11(4):e0153436. doi: 10.1371/journal.pone.0153436. eCollection 2016.
Proteases are widely used to remove affinity and solubility tags from recombinant proteins to avoid potential interference of these tags with the structure and function of the fusion partner. In recent years, great interest has been seen in use of the human rhinovirus 3C protease owing to its stringent sequence specificity and enhanced activity. Like other proteases, activity of the human rhinovirus 3C protease can be affected in part by the buffer components and additives that are generally employed for purification and stabilization of proteins, hence, necessitate their removal by tedious and time-consuming procedures before proteolysis can occur. To address this issue, we examined the effect of elution buffers used for common affinity based purifications, salt ions, stability/solubility and reducing agents, and detergents on the activity of the human rhinovirus 3C protease using three different fusion proteins at 4°C, a temperature of choice for purification of many proteins. The results show that the human rhinovirus 3C protease performs better at 4°C than the frequently used tobacco etch virus protease and its activity was insensitive to most of the experimental conditions tested. Though number of fusion proteins tested is limited, we expect that these finding will facilitate the use of the human rhinovirus 3C protease in recombinant protein production for pharmaceutical and biotechnological applications.
蛋白酶被广泛用于从重组蛋白中去除亲和标签和溶解性标签,以避免这些标签对融合伴侣的结构和功能产生潜在干扰。近年来,由于人鼻病毒3C蛋白酶具有严格的序列特异性和增强的活性,人们对其应用产生了浓厚兴趣。与其他蛋白酶一样,人鼻病毒3C蛋白酶的活性会部分受到通常用于蛋白质纯化和稳定化的缓冲液成分及添加剂的影响,因此,在进行蛋白酶解之前,需要通过繁琐且耗时的程序将它们去除。为了解决这个问题,我们在4℃(许多蛋白质纯化所选择的温度)下,使用三种不同的融合蛋白,研究了用于常见亲和纯化的洗脱缓冲液、盐离子、稳定性/溶解性、还原剂和去污剂对人鼻病毒3C蛋白酶活性的影响。结果表明,人鼻病毒3C蛋白酶在4℃下的表现优于常用的烟草蚀纹病毒蛋白酶,并且其活性对所测试的大多数实验条件不敏感。尽管所测试的融合蛋白数量有限,但我们预计这些发现将有助于人鼻病毒3C蛋白酶在制药和生物技术应用的重组蛋白生产中的使用。